Crossmark

Health-related quality of life and cost comparison of adjuvant capecitabine versus 5-fluorouracil/leucovorin in stage III colorectal cancer patients

Crossref DOI link: https://doi.org/10.1007/s11136-014-0773-x

Published Online: 2014-08-07

Published Print: 2015-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Hong-Hwa

Chen, William Tzu-Liang

Lee, Hsin-Chung

Lin, Jen-Kou

Fang, Chuan-Yin

Chou, Yenn-Hwei

Lin, Peng-Chan

Lin, Bo-Wen

Huang, Chi-Chou

Yeh, Chung-Hung

Hsu, Hsi-Hsien

Chen, Hung-Chang

Ting, Wen-Chien

Yang, Ming-Chin

Tan, Elise Chia-Hui
License Information

Text and Data Mining valid from 2014-08-07